Japanese start-up Minma, which operates P2P jobs and services marketplace Curama, has raised a JPY4 billion ($36.5 million) Series C round led by Nissay Capital, the VC unit of Nippon Life Insurance.
This is the first investment by Nissay’s recently established JPY10 billion pre-IPO fund, which targets companies with market capitalizations in excess of JPY50 billion. Nissay previously participated...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.